Inflammatory muscle disease assessment.
In recent years, idiopathic inflammatory muscle disease assessment has advanced significantly with the development of an international consensus on outcome measurement indices. The International Myositis Assessment and Clinical Studies Group continues to evaluate the validity and reliability of various disease activity and disease damage tools, which will facilitate adequately controlled randomized trials of recently developed therapeutic agents.
Lu
Tim Y-T
TY
Centre for Rheumatology, Room 331, 3rd Floor, Windeyer Building, University College London, 46 Cleveland Street, London W1T4JF, United Kingdom.
Ng
Kristine P
KP
Isenberg
David A
DA
D015415:Biomarkers; D004576:Electromyography; D006801:Humans; D008279:Magnetic Resonance Imaging; D009220:Myositis / Q000175:diagnosis* / Q000473:pathology*; D011788:Quality of Life; D012720:Severity of Illness Index
D015415:Biomarkers